Mesenchymal-Stromal-Cell Therapy Effective Long-Term for Crohn ' s Disease Perianal Fistulas Mesenchymal-Stromal-Cell Therapy Effective Long-Term for Crohn ' s Disease Perianal Fistulas

Most patients with Crohn ' s disease whose perianal fistulas close after allogeneic bone marrow-derived mesenchymal stromal cell (bmMSC) therapy remain fistula-free four years later, researchers from the Netherlands report.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news